Related Experiment Video
Updated: Apr 21, 2026

07:05
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
9.2K
Taking supplements is clinically unwarranted in dementia care
1Care of the older person.
Nursing Older People
|November 1, 2014
Summary
Many supplements like vitamin E and ginkgo biloba are used for memory issues but can interact with medications. Be aware of potential drug interactions, especially with blood thinners, to avoid adverse effects.
Area of Science:
- Pharmacology
- Gerontology
- Nutritional Science
Background:
- Dietary supplements including B vitamins, vitamin D, vitamin E, omega-3 fatty acids, and ginkgo biloba are widely used for cognitive health.
- These supplements are often taken to address memory complaints and manage dementia symptoms.
Purpose of the Study:
- To investigate the potential for drug interactions between common dietary supplements and prescription medications.
- To highlight the risks associated with combining certain supplements with specific drug classes.
Main Methods:
- Literature review of studies on supplement-drug interactions.
- Analysis of reported adverse events and pharmacological mechanisms.
Main Results:
- Supplements such as vitamin E and ginkgo biloba can increase bleeding risk.
- Concurrent use of these supplements with anticoagulant medications (e.g., warfarin) is contraindicated.
- Potential interactions exist for other supplements and prescription drugs, requiring careful consideration.
Conclusions:
- Consumers and healthcare providers must be aware of potential drug interactions with dietary supplements.
- Caution is advised when using supplements like vitamin E and ginkgo biloba alongside anticoagulant therapy due to increased bleeding risk.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
900
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
900
Drug Dosing: Geriatric Patients
387
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
387
Vitamins
2.6K
Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.6K
Pharmacodynamics in Geriatric Patients: Effects of Age
351
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
351
Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Dementia
672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
672
